NovoCure Share Price

NovoCure Share Price

NASDAQ: NVCR | Small Cap | Healthcare
$10.71
+$0.04 (0.33%) Last updated on 21 Nov, 2026 | 02:30 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

NovoCure Stock Performance

Open
$10.65
Prev. Close
$10.68
Circuit Range
N/A
Day Range
$10.65 - $11.01
Year Range
$9.83 - $21.31
Volume
1,03,545
Average Traded
$10.77

NovoCure Share Price Today

As of 23 November 2026, NovoCure Limited's share price is $10.71. The stock opened at $10.65, compared to its previous close of $10.68. During today's trading session, NovoCure Limited's share price traded between $10.65 and $11.01, with an average price of $10.83. Over the past 52 weeks, the stock has recorded a high of $21.31 and a low of $9.83. In terms of performance, NovoCure Limited's share price has declined by 37.15% over the last six months and is down 16.33% on a year-on-year basis.

NovoCure Share Price Chart

Line chart of the NovoCure price trend over the selected period. The price rose overall, ranging from 10.62 to 11.04, ending at 10.71.
$10.65$11.01
L
Show Current Price
H

NovoCure Stock Fundamentals & Key Indicators

Market Cap
$1.19B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.04
Revenue (TTM)
$655.35B
Return On Equity (TTM)
-34.72%
Profit Margin
-20.79%
Debt to Equity
0.56
Quarterly Earnings Growth YoY
57.39%

NovoCure Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$174.35$174.06$183.58$193.40
Net Profit-$24.50-$71.14-$15.66-$10.44
Net Profit Margin-14.05%-40.87%-8.53%-5.40%
Income ChangeN/A-190.37%77.99%33.33%

NovoCure Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$537.84$509.34$605.22$655.35
Net Profit-$92.53-$207.04-$168.63-$136.23
Net Profit Margin-17.20%-40.65%-27.86%-20.79%
Income ChangeN/A-123.75%18.55%19.21%

NovoCure Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets157.6134.21111.7280.12
Current Assets646.731106.581034.411111.53
Total Assets804.331240.781146.131191.65
Non Current Liabilities240.63124.21604.52591.7
Current Liabilities223.23756.39179.12158.78
Total Liabilities463.86880.61783.63750.48
Shareholders' Equity340.47360.18362.5441.17

NovoCure Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-49.03-26.37-73.3430.79
Investing437.28-140.24184.15-139.96
Financing-451.3490.3215.7915.49

About NovoCure

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

NovoCure Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$13.36
$10.69
-18.92%
Oct 2026
$15.88
$13.19
-17.49%
Sep 2026
$17.51
$15.98
-11.17%
Aug 2026
$15.05
$17.99
+21.14%
Jul 2026
$15.38
$14.85
-1.75%
Jun 2026
$17.18
$15.12
-11.30%
May 2026
$15.40
$17.04
+12.14%
Apr 2026
$11.08
$15.20
+39.28%
Mar 2026
$13.63
$10.91
-20.10%
Feb 2026
$12.25
$13.65
+9.94%
Jan 2026
$12.97
$12.42
-3.80%
Dec 2025
$12.12
$12.91
+0.86%

NovoCure Share Price FAQs